Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma

Authors

Christina D. Enescu
Christina Artz, Henry Ford HealthFollow
Anna Axelson, Henry Ford HealthFollow

Recommended Citation

Enescu CD, Artz C, and Axelson A. Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma. JAAD Case Rep 2022; 21:140-143.

Document Type

Article

Publication Date

3-1-2022

Publication Title

JAAD Case Rep

PubMed ID

35242967

Volume

21

First Page

140

Last Page

143